ITOS
iTeos Therapeutics (ITOS)
$95
About iTeos Therapeutics (ITOS)
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Details
Daily high
$10.20
Daily low
$9.11
Price at open
$9.11
52 Week High
$18.75
52 Week Low
$8.45
Market cap
363.4M
Dividend yield
0.00%
Volume
800,554
Avg. volume
915,869
P/E ratio
-3.32
iTeos Therapeutics News
Details
Daily high
$10.20
Daily low
$9.11
Price at open
$9.11
52 Week High
$18.75
52 Week Low
$8.45
Market cap
363.4M
Dividend yield
0.00%
Volume
800,554
Avg. volume
915,869
P/E ratio
-3.32